China Resources Double-Crane Pharmaceutical Co., Ltd.SSE: 600062

Announcement on Obtaining Drug Registration Certificate for Some Drugs by Subsidiary

· Issued by China Resources Double-Crane Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 7 pages · Chinese

Summary by 6ix AI

China Resources Double-Crane Pharmaceutical Co., Ltd. announced that its subsidiaries have obtained drug registration certificates for several products. The registered drugs include Linagliptin and Metformin Hydrochloride Tablets, Progesterone Injection, and Vortioxetine Hydrobromide Tablets. The filing also includes a risk warning regarding the uncertainties in the pharmaceutical market.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Obtaining Drug Registration Certificate for Some Drugs by Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

China Resources Double-Crane Pharmaceutical Co., Ltd. on 6ix

Earlier from China Resources Double-Crane Pharmaceutical

Later from China Resources Double-Crane Pharmaceutical

All China Resources Double-Crane Pharmaceutical news releases